Freeline Therapeutics Holdings Plc (FRLN)
$0.00 $0.00 (0.00%) 10:34 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$28.24M -
Day's Range
- - - -
Volume
10,707 -
52 Week Low / High
$6.30 - $6.49 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
FRLN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $12.80
- Target Price
Company News
-
Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why — Jan 12th, 2024
Shares of Amicus Therapeutics, Inc. FOLD have rallied 27.9% in the past three months compared with the industry’s increase of 10.7%. In late September 2023, the FDA approved Pombiliti + Opfolda, a two-component therapy for treating late-onset Pompe disease (LOPD) in adults who weigh mor...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$